After 500% Surge, Mirati’s Day of Reckoning Is Approaching

(Bloomberg) -- With no drugs on the market and no earnings to speak of, Mirati Therapeutics Inc. has soared more than 500% since September 2017.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.